Fundación Jimenez Diaz
Welcome,         Profile    Billing    Logout  
 16 Trials 
23 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Casado, Victoria
FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting
3
615
Europe, Canada, US, RoW
Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo
CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd
Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms
09/25
08/27
Casas, Ana Mª Perez
NCT03476473: Early Detection of Respiratory Disorders in Psychosis

Enrolling by invitation
N/A
200
Europe
Fundación Marques de Valdecilla, Instituto de Investigación Marqués de Valdecilla, Consorcio Centro de Investigación Biomédica en Red, M.P.
Schizophrenia, Psychosis, Chronic Respiratory Disease
03/18
12/20
Casal, Joaquin
NADIM-ADJUVANT, NCT04564157: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Active, not recruiting
3
210
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP
Non-Small Cell Lung Cancer, Adjuvant Chemotherapy
04/30
04/31
DUMAS, NCT05684276 / 2022-003717-11: Neo-Adjuvant Immunotherapy for Pancoast Tumors

Recruiting
2
22
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP, Bristol-Myers Squibb Pharma
NSCLC, Pancoast Tumor
03/28
06/28
NCT02941458: Thoracic Tumours Register

Recruiting
N/A
10000
Europe
Spanish Lung Cancer Group
Thoracic Tumors
12/25
12/30
Dómine, Manuel
ARIAN, NCT06431633: Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Recruiting
3
129
Europe
Zimberelimab, anti-PD-1 monoclonal antibody AB122, Sacituzumab govitecan, Trodelvy, Cisplatin, Platinol, Carboplatin, Paraplatin
Fundación GECP
Lung Diseases, Carcinoma, Non-Small-Cell Lung, Resectable Lung Non-Small Cell Carcinoma
11/31
11/31
NADIM-ADJUVANT, NCT04564157: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Active, not recruiting
3
210
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP
Non-Small Cell Lung Cancer, Adjuvant Chemotherapy
04/30
04/31
Replay, NCT03526887: Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC

Completed
2
73
Europe
Pembrolizumab, KEYTRUDA
Spanish Lung Cancer Group
Lung Cancer
12/22
03/23
NCT03293680: Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Completed
2
83
Europe
Pembrolizumab, KEYTRUDA
Spanish Lung Cancer Group
Non Small Cell Lung Cancer
04/23
07/23
GECP 20/01_Neo-DIANA, NCT04512430: Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Terminated
2
4
Europe
Atezolizumab, Tecentriq, Bevacizumab, Avastin, Carboplatin, Paraplatin, Pemetrexed, Alimta
Fundación GECP
Non Small Cell Lung Cancer, EGFR Gene Mutation
07/24
07/24
BIMES, NCT05005429 / 2020-004902-67: Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

Completed
2
47
Europe
Bintrafusp alfa, M7824
Fundación GECP
Mesothelioma; Lung
02/24
02/24
PALACE, NCT06917573: Cemiplimab Trial According to ctDNA Levels

Not yet recruiting
2
63
Europe
Cemiplimab, REGN2810, Carboplatin, Paraplatin, Carboplatine, Paclitaxel, Taxol
Fundación GECP
Non Small Cell Lung Cancer Metastatic, Lung Diseases, Stage IV Non-small Cell Lung Cancer, Stage III Non-small Cell Lung Cancer, Respiratory Tract Neoplasms, Thoracic Neoplasms
12/31
12/31
ADEPPT, NCT05673187 / 2022-002736-31: Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status

Recruiting
2
68
Europe
Adagrasib
ETOP IBCSG Partners Foundation, Mirati Therapeutics Inc.
NSCLC Stage IV, KRAS P.G12C
10/25
03/26
NIVIPI-Brain, NCT05012254 / 2021-000425-27: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Active, not recruiting
2
71
Europe
Ipilimumab, Yervoy, Nivolumab, Opdivo, Carboplatin, Paraplatin, Cisplatin, Cis-diamminedichloroplatinum, Platinol, Paclitaxel, Taxol, Pemetrexed, Pemetrexed disodium; ALIMTA
Fundación GECP, Fundación GECP
Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer
03/26
12/26
PEERS, NCT05384015 / 2020-005230-15: Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer

Recruiting
2
46
Europe
Lenvatinib, LENVIMA, KISPLYX, Pembrolizumab, KEYTRUDA, Etoposide, Etoposide Tevagen, Carboplatin, Carboplatin Accord
Fundación GECP, Merck Sharp & Dohme LLC
Small Cell Lung Cancer Extensive Stage
07/26
07/27
APOLO, NCT04776447 / 2020-004459-33: Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy.

Active, not recruiting
2
38
Europe
Carboplatin, Carboplatinum, Placlitaxel, Taxol, Atezolizumab, Tecentriq
Fundación GECP
Lung Diseases, Carcinoma, Non-Small-Cell Lung, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Respiratory Tract Neoplasms, Carcinoma Bronchiogenic Stage III, Thoracic Neoplasms
11/26
11/27
MERIT-lung, NCT05398094 / 2021-004576-34: Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Recruiting
2
19
Europe
Sotorasib, AMG510
Fundación GECP, Fundación GECP
Non-small Cell Lung Cancer Stage III, KRAS P.G12C
12/27
12/28
DUMAS, NCT05684276 / 2022-003717-11: Neo-Adjuvant Immunotherapy for Pancoast Tumors

Recruiting
2
22
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP, Bristol-Myers Squibb Pharma
NSCLC, Pancoast Tumor
03/28
06/28
LUDICAS, NCT06018376: Characteristics of Sexual Dysfunction in Patients With Lung Cancer

Completed
N/A
553
Europe, RoW
Systemic oncological treatment, chemotherapy, radiotherapy
Fundación GECP
Lung Cancer, Sexual Dysfunction
02/24
02/24
SIENNA, NCT06634199: Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Recruiting
N/A
50
Europe
Durvalumab, Imfinzi
Fundación GECP
Non-small Cell Lung Cancer Stage III, PDL1 Gene Mutation
11/27
11/27
NCT02941458: Thoracic Tumours Register

Recruiting
N/A
10000
Europe
Spanish Lung Cancer Group
Thoracic Tumors
12/25
12/30
Llamas, Pilar
NCT02832245: Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Recruiting
N/A
120000
Europe, Japan, US, RoW
Manuel Monreal
Venous Thromboembolism
12/26
12/27
IBAÑEZ, BORJA
DapaTAVI, NCT04696185: Dapagliflozin After Transcatheter Aortic Valve Implantation

Completed
4
1257
Europe
Dapagliflozin 10 MG
Spanish Society of Cardiology, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Aortic Stenosis, Transcatether Aortic Valve Implantation
12/24
12/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Casado, Victoria
FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting
3
615
Europe, Canada, US, RoW
Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo
CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd
Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms
09/25
08/27
Casas, Ana Mª Perez
NCT03476473: Early Detection of Respiratory Disorders in Psychosis

Enrolling by invitation
N/A
200
Europe
Fundación Marques de Valdecilla, Instituto de Investigación Marqués de Valdecilla, Consorcio Centro de Investigación Biomédica en Red, M.P.
Schizophrenia, Psychosis, Chronic Respiratory Disease
03/18
12/20
Casal, Joaquin
NADIM-ADJUVANT, NCT04564157: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Active, not recruiting
3
210
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP
Non-Small Cell Lung Cancer, Adjuvant Chemotherapy
04/30
04/31
DUMAS, NCT05684276 / 2022-003717-11: Neo-Adjuvant Immunotherapy for Pancoast Tumors

Recruiting
2
22
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP, Bristol-Myers Squibb Pharma
NSCLC, Pancoast Tumor
03/28
06/28
NCT02941458: Thoracic Tumours Register

Recruiting
N/A
10000
Europe
Spanish Lung Cancer Group
Thoracic Tumors
12/25
12/30
Dómine, Manuel
ARIAN, NCT06431633: Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Recruiting
3
129
Europe
Zimberelimab, anti-PD-1 monoclonal antibody AB122, Sacituzumab govitecan, Trodelvy, Cisplatin, Platinol, Carboplatin, Paraplatin
Fundación GECP
Lung Diseases, Carcinoma, Non-Small-Cell Lung, Resectable Lung Non-Small Cell Carcinoma
11/31
11/31
NADIM-ADJUVANT, NCT04564157: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Active, not recruiting
3
210
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP
Non-Small Cell Lung Cancer, Adjuvant Chemotherapy
04/30
04/31
Replay, NCT03526887: Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC

Completed
2
73
Europe
Pembrolizumab, KEYTRUDA
Spanish Lung Cancer Group
Lung Cancer
12/22
03/23
NCT03293680: Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Completed
2
83
Europe
Pembrolizumab, KEYTRUDA
Spanish Lung Cancer Group
Non Small Cell Lung Cancer
04/23
07/23
GECP 20/01_Neo-DIANA, NCT04512430: Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Terminated
2
4
Europe
Atezolizumab, Tecentriq, Bevacizumab, Avastin, Carboplatin, Paraplatin, Pemetrexed, Alimta
Fundación GECP
Non Small Cell Lung Cancer, EGFR Gene Mutation
07/24
07/24
BIMES, NCT05005429 / 2020-004902-67: Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

Completed
2
47
Europe
Bintrafusp alfa, M7824
Fundación GECP
Mesothelioma; Lung
02/24
02/24
PALACE, NCT06917573: Cemiplimab Trial According to ctDNA Levels

Not yet recruiting
2
63
Europe
Cemiplimab, REGN2810, Carboplatin, Paraplatin, Carboplatine, Paclitaxel, Taxol
Fundación GECP
Non Small Cell Lung Cancer Metastatic, Lung Diseases, Stage IV Non-small Cell Lung Cancer, Stage III Non-small Cell Lung Cancer, Respiratory Tract Neoplasms, Thoracic Neoplasms
12/31
12/31
ADEPPT, NCT05673187 / 2022-002736-31: Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status

Recruiting
2
68
Europe
Adagrasib
ETOP IBCSG Partners Foundation, Mirati Therapeutics Inc.
NSCLC Stage IV, KRAS P.G12C
10/25
03/26
NIVIPI-Brain, NCT05012254 / 2021-000425-27: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Active, not recruiting
2
71
Europe
Ipilimumab, Yervoy, Nivolumab, Opdivo, Carboplatin, Paraplatin, Cisplatin, Cis-diamminedichloroplatinum, Platinol, Paclitaxel, Taxol, Pemetrexed, Pemetrexed disodium; ALIMTA
Fundación GECP, Fundación GECP
Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer
03/26
12/26
PEERS, NCT05384015 / 2020-005230-15: Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer

Recruiting
2
46
Europe
Lenvatinib, LENVIMA, KISPLYX, Pembrolizumab, KEYTRUDA, Etoposide, Etoposide Tevagen, Carboplatin, Carboplatin Accord
Fundación GECP, Merck Sharp & Dohme LLC
Small Cell Lung Cancer Extensive Stage
07/26
07/27
APOLO, NCT04776447 / 2020-004459-33: Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy.

Active, not recruiting
2
38
Europe
Carboplatin, Carboplatinum, Placlitaxel, Taxol, Atezolizumab, Tecentriq
Fundación GECP
Lung Diseases, Carcinoma, Non-Small-Cell Lung, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Respiratory Tract Neoplasms, Carcinoma Bronchiogenic Stage III, Thoracic Neoplasms
11/26
11/27
MERIT-lung, NCT05398094 / 2021-004576-34: Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Recruiting
2
19
Europe
Sotorasib, AMG510
Fundación GECP, Fundación GECP
Non-small Cell Lung Cancer Stage III, KRAS P.G12C
12/27
12/28
DUMAS, NCT05684276 / 2022-003717-11: Neo-Adjuvant Immunotherapy for Pancoast Tumors

Recruiting
2
22
Europe
Carboplatin, Paraplatin, Paclitaxel, Taxol, Nivolumab, Opdivo
Fundación GECP, Bristol-Myers Squibb Pharma
NSCLC, Pancoast Tumor
03/28
06/28
LUDICAS, NCT06018376: Characteristics of Sexual Dysfunction in Patients With Lung Cancer

Completed
N/A
553
Europe, RoW
Systemic oncological treatment, chemotherapy, radiotherapy
Fundación GECP
Lung Cancer, Sexual Dysfunction
02/24
02/24
SIENNA, NCT06634199: Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Recruiting
N/A
50
Europe
Durvalumab, Imfinzi
Fundación GECP
Non-small Cell Lung Cancer Stage III, PDL1 Gene Mutation
11/27
11/27
NCT02941458: Thoracic Tumours Register

Recruiting
N/A
10000
Europe
Spanish Lung Cancer Group
Thoracic Tumors
12/25
12/30
Llamas, Pilar
NCT02832245: Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Recruiting
N/A
120000
Europe, Japan, US, RoW
Manuel Monreal
Venous Thromboembolism
12/26
12/27
IBAÑEZ, BORJA
DapaTAVI, NCT04696185: Dapagliflozin After Transcatheter Aortic Valve Implantation

Completed
4
1257
Europe
Dapagliflozin 10 MG
Spanish Society of Cardiology, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Aortic Stenosis, Transcatether Aortic Valve Implantation
12/24
12/24

Download Options